Emergent Biosolutions has announced the selection of its spin-off company’s board of directors. The spin-off company, Aptevo Therapeutics Inc., was announced by the Emergent in August. According to an earlier report from Bio Prep Watch, the company will be focused on therapeutics development in oncology and hematology.